WO2008034430A3 - Serumfreies medium zur differenzierung von stammzellen - Google Patents
Serumfreies medium zur differenzierung von stammzellen Download PDFInfo
- Publication number
- WO2008034430A3 WO2008034430A3 PCT/DE2007/001694 DE2007001694W WO2008034430A3 WO 2008034430 A3 WO2008034430 A3 WO 2008034430A3 DE 2007001694 W DE2007001694 W DE 2007001694W WO 2008034430 A3 WO2008034430 A3 WO 2008034430A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- differentiation
- serum
- stem cells
- free medium
- polypeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Selective Calling Equipment (AREA)
Abstract
Die vorliegende Erfindung betrifft eine synthetische Zusammensetzung, die ein Polypeptid, das die Aminosäuresequenz von SEQ ID NO: 1 umfasst, ein Polypeptid, das die Aminosäuresequenz von SEQ ID NO: 3 umfasst, ein Polypeptid, das die Aminosäuresequenz von SEQ ID NO: 5 umfasst, und Ascorbinsäure umfasst. Insbesondere betrifft die vorliegende Erfindung eine synthetische Zusammensetzung, die BMP-2 (Bone Morphogenetic Protein-2), BMP-4 (Bone Morphogenetic Protein-4), Aktivin A und Ascorbinsäure umfasst. In einem weiteren Aspekt betrifft die vorliegende Erfindung ein Zellkulturmedium bzw. ein Stammzelldifferenzierungsmedium, das die erfindungsgemäße Zusammensetzung umfasst.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/087,257 US20090267806A1 (en) | 2006-09-19 | 2007-09-20 | Electrical Circuit |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006043891A DE102006043891B4 (de) | 2006-09-19 | 2006-09-19 | Serumfreies Medium zur Differenzierung von Stammzellen |
DE102006043891.4 | 2006-09-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008034430A2 WO2008034430A2 (de) | 2008-03-27 |
WO2008034430A3 true WO2008034430A3 (de) | 2008-06-12 |
Family
ID=39104920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2007/001694 WO2008034430A2 (de) | 2006-09-19 | 2007-09-19 | Serumfreies medium zur differenzierung von stammzellen |
Country Status (3)
Country | Link |
---|---|
US (1) | US20090267806A1 (de) |
DE (1) | DE102006043891B4 (de) |
WO (1) | WO2008034430A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9765298B2 (en) | 2006-07-24 | 2017-09-19 | Mayo Foundation For Medical Education And Research | Methods and materials for providing cardiac cells |
WO2009145761A1 (en) * | 2008-05-27 | 2009-12-03 | Mayo Foundation For Medical Education And Research | Methods and materials for using cells to treat heart tissue |
US11078248B2 (en) | 2010-03-19 | 2021-08-03 | Lifenet Health | BMP peptides and methods of use |
WO2011116391A1 (en) * | 2010-03-19 | 2011-09-22 | Lifenet Health | Bmp-2 peptides & methods of use |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006083782A2 (en) * | 2005-01-31 | 2006-08-10 | Es Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4560909A (en) * | 1982-09-28 | 1985-12-24 | General Electric Company | Dual load remote power control for a ceiling fan |
US4716409A (en) * | 1986-07-16 | 1987-12-29 | Homestead Products, Inc. | Electrical appliance control system |
US5189412A (en) * | 1990-05-11 | 1993-02-23 | Hunter Fan Company | Remote control for a ceiling fan |
US5365154A (en) * | 1991-07-12 | 1994-11-15 | North Coast Electronics, Inc. | Appliance control system and method |
US5504400A (en) * | 1994-09-23 | 1996-04-02 | Dalnodar; David C. | Two-channel AC light dimmer and lighting system |
US6120262A (en) * | 1998-10-07 | 2000-09-19 | Emerson Electric Co. | Electronic device control system |
WO2006047743A2 (en) * | 2004-10-26 | 2006-05-04 | Regents Of The University Of Minnesota | Swine multipotent adult progenitor cells |
US7728564B2 (en) * | 2005-06-06 | 2010-06-01 | Lutron Electronics Co., Inc. | Power supply for a load control device |
-
2006
- 2006-09-19 DE DE102006043891A patent/DE102006043891B4/de not_active Expired - Fee Related
-
2007
- 2007-09-19 WO PCT/DE2007/001694 patent/WO2008034430A2/de active Application Filing
- 2007-09-20 US US12/087,257 patent/US20090267806A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006083782A2 (en) * | 2005-01-31 | 2006-08-10 | Es Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
Non-Patent Citations (2)
Title |
---|
SEILER ANDREA E M ET AL: "Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test", METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS INC., CLIFTON, NJ, US, vol. 329, 2006, pages 371 - 395, XP009094398, ISSN: 1064-3745 * |
SEILER ANDREA ET AL: "Current status of the embryonic stem cell test: the use of recent advances in the field of stem cell technology and gene expression analysis.", ALTEX : ALTERNATIVEN ZU TIEREXPERIMENTEN 2006, vol. 23 Suppl, 2006, pages 393 - 399, XP009098539, ISSN: 0946-7785 * |
Also Published As
Publication number | Publication date |
---|---|
US20090267806A1 (en) | 2009-10-29 |
DE102006043891B4 (de) | 2013-04-18 |
DE102006043891A1 (de) | 2008-03-27 |
WO2008034430A2 (de) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007051038A3 (en) | Pdx1-expressing dorsal and ventral foregut endoderm | |
Betre et al. | Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide | |
WO2007030652A3 (en) | Methods and compositions for growing adipose stem cells | |
SG152273A1 (en) | Pdx1 expressing endoderm | |
WO2006056885A3 (en) | Igf-1 isoforms | |
EP2455461A3 (de) | Lipasevarianten zur pharmazeutischen Verwendung | |
WO2008070082A3 (en) | Stem-progenitor cell specific micro-ribonucleic acids and uses thereof | |
WO2005016283A3 (en) | Peptides for enhanced cell attachment and growth | |
WO2004072100A3 (en) | Nell peptide expression systems and bone formation activity of nell peptide | |
WO2006008653A3 (en) | Lipolytic enzyme uses thereof in the food industry | |
NZ596231A (en) | Manipulating fructan biosynthesis and enhancing plant biomass | |
EP1835028A4 (de) | Transkriptionsfaktor-gen osnacx aus reis und verwendung davon zur verbesserung der toleranz von pflanzen gegenüber trockenheit und salz | |
WO2007009094A3 (en) | Antisense antibacterial method and compound | |
EP2351839A3 (de) | Antisinn antibakterielle verfahren und verbindungen | |
MX2007002380A (es) | Produccion de polipeptidos. | |
WO2002042424A3 (en) | Seed-preferred regulatory elements and uses thereof | |
WO2007087436A3 (en) | Modification of chemical forces of bone constructs | |
WO2006035221A3 (en) | Modification of plant development and morphology | |
WO2007011610A3 (en) | Protein formulation for promoting hard tissue formation | |
WO2006105361A3 (en) | Inhibitors of ribonucleotide reductase subunit 2 and uses thereof | |
WO2008038287A3 (en) | N-terminal fgf variants having increased receptor selectivity and uses thereof | |
WO2006082254A3 (en) | Microorganisms comprising enzymes expressed with low gamma-elimination activity | |
WO2008034430A3 (de) | Serumfreies medium zur differenzierung von stammzellen | |
WO2003091398A3 (en) | Compositions and methods for stem cell delivery | |
ATE289351T1 (de) | Für eine cinnamoyl-coa-reduktase kodierende dna sequenzen, und ihre verwendung zur regulation des lignun-gehalts von pflanzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07817545 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12087257 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |